KVÅKVÅ3E033VH — Introduction of Human B-type Natriuretic Peptide into Peripheral Vein, Percutaneous Approach
KVÅKVÅ3E050VH — Introduction of Human B-type Natriuretic Peptide into Peripheral Artery, Open Approach
KVÅKVÅ3E053VH — Introduction of Human B-type Natriuretic Peptide into Peripheral Artery, Percutaneous Approach
KVÅKVÅ3E043VH — Introduction of Human B-type Natriuretic Peptide into Central Vein, Percutaneous Approach
KVÅKVÅ3E063VH — Introduction of Human B-type Natriuretic Peptide into Central Artery, Percutaneous Approach
KVÅKVÅ3E03316 — Introduction of Recombinant Human-activated Protein C into Peripheral Vein, Percutaneous
KVÅKVÅ3E04316 — Introduction of Recombinant Human-activated Protein C into Central Vein, Percutaneous
KVÅKVÅ3E05316 — Introduction of Recombinant Human-activated Protein C into Peripheral Artery, Percutaneous
KVÅKVÅ3E06316 — Introduction of Recombinant Human-activated Protein C into Central Artery, Percutaneous
KVÅKVÅ3E07316 — Introduction of Recombinant Human-activated Protein C into Coronary Artery, Percutaneous
KVÅKVÅ3E00X05 — Introduction of Other Antineoplastic into Skin and Mucous Membranes, External Approach
KVÅKVÅ3E00X0M — Introduction of Antineoplastic, Monoclonal Antibody, into Skin and Mucous Membranes, External Approach
KVÅKVÅ3E00X29 — Introduction of Other Anti-infective into Skin and Mucous Membranes, External Approach
KVÅKVÅ3E00X4Z — Introduction of Serum, Toxoid and Vaccine into Skin and Mucous Membranes, External Approach
KVÅKVÅ3E00XGC — Introduction of Other Therapeutic Substance into Skin and Mucous Membranes, External Approach
KVÅKVÅ3E00XKZ — Introduction of Other Diagnostic Substance into Skin and Mucous Membranes, External Approach
KVÅKVÅ3E00XNZ — Introduction of Analgesics, Hypnotics, Sedatives into Skin and Mucous Membranes, External Approach
KVÅKVÅ3E0130M — Introduction of Antineoplastic, Monoclonal Antibody, into Subcutaneous Tissue, Percutaneous Approach
KVÅKVÅ3E0132A — Introduction of Anti-Infective Envelope into Subcutaneous Tissue, Percutaneous Approach
KVÅKVÅ3E0134Z — Introduction of Serum, Toxoid and Vaccine into Subcutaneous Tissue, Percutaneous Approach
KVÅKVÅ3E0136Z — Introduction of Nutritional Substance into Subcutaneous Tissue, Percutaneous Approach
KVÅKVÅ3E0137Z — Introduction of Electrolytic and Water Balance Substance into Subcutaneous Tissue, Percutaneous Approach
KVÅKVÅ3E013GC — Introduction of Other Therapeutic Substance into Subcutaneous Tissue, Percutaneous Approach
KVÅKVÅ3E013HZ — Introduction of Radioactive Substance into Subcutaneous Tissue, Percutaneous Approach
KVÅKVÅ3E013KZ — Introduction of Other Diagnostic Substance into Subcutaneous Tissue, Percutaneous Approach
KVÅKVÅ3E013NZ — Introduction of Analgesics, Hypnotics, Sedatives into Subcutaneous Tissue, Percutaneous Approach
KVÅKVÅ3E0230M — Introduction of Antineoplastic, Monoclonal Antibody, into Muscle, Percutaneous Approach
KVÅKVÅ3E0237Z — Introduction of Electrolytic and Water Balance Substance into Muscle, Percutaneous Approach
